PATENT CLAIM ANALYSIS

Application Number: 15768001
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "651000"]

Abstract:
The present invention relates to the field of myocardial infraction (MI). It more specifically relates to an agent stimulating, either directly or indirectly, the 5-hydroxytryptamine 1B receptor, and to a composition comprising said agent, for use in the treatment of a patient having a myocardial infraction (MI). The invention further encompasses therapeutic and screening methods.

Claim (Index 7):
The agent for use according to  claim 6 , wherein\n said quaternary ammonium group has the formula (I)\n \u2014(NR 1 R 2 R 3 ) + Z \u2212 \u2003\u2003(I) \n wherein Z is an organic or inorganic anion; and R 1 , R 2  and R 3  are each independently selected from the group consisting of alkyl, aryl and cycloalkyl; or said tertiary sulfonium group has the formula (II)\n \u2014(SR 4 R 5 ) + Z \u2212 \u2003\u2003(11) \n wherein Z is an organic or inorganic anion; and R 4  and R 5  are each independently selected from the group consisting of alkyl, aryl and cycloalkyl.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15744345', '15548555', '15106286', '13757944', '11667899']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7334562443640495
- 35 USC 102 Novelty (BERT): 0.5234026667339376
- Combined Prediction Score: 0.7124508866010384
- Mean Citation Score: 175.44384800000003
- Max Citation Score: 301.73428
- Similarity Product: 214.76404105222463

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test